Skip to NavigationSkip to content

News

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an...
Check out the Top Ten most popular articles on Pharmafile.com this week!
India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new...
It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health and Care Excellence (NICE...
The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy designation...
British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines.
American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%.
Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic drug approvals this...
An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International.
The US regulator authorised Shionogi’s Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients older than 12...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches